Skip to search formSkip to main contentSkip to account menu

Glucagon-Like Peptide 1

Known as: GLP 1, Glucagon-Like Peptide 1 [Chemical/Ingredient], Glucagon Like Peptide 1 
A peptide of 36 or 37 amino acids that is derived from PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. GLP-1(1-37 or 1-36) is further N… 
National Institutes of Health

Related topics

Related topics

30 relations
0.5 ML dulaglutide 3 MG/ML Auto-Injector3 ML Lixisenatide 0.1 MG/ML Pen Injector3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]3 ML liraglutide 6 MG/ML Pen Injector [Victoza]

Narrower (5)

BIM 51077LY307161glucagon-like peptide 1 (7-36)amideglucagon-like peptide 1 (7-37)

Broader (1)

Incretins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes…
OBJECTIVE To evaluate the efficacy and safety of taspoglutide (R1583/BIM51077), a human once-weekly glucagon-like peptide-1… 
Highly Cited
2006
Highly Cited
2006
PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice
Aims/hypothesisThe rapid degradation and clearance of glucagon-like peptide-1 (GLP-1) by the enzymes dipeptidyl peptidase-IV and… 
Highly Cited
2003
Highly Cited
2003
Three Distinct Epitopes on the Extracellular Face of the Glucagon Receptor Determine Specificity for the Glucagon Amino Terminus*
The glucagon and glucagon-like peptide-1 (GLP-1) receptors are homologous family B seven-transmembrane (7TM) G protein-coupled… 
Highly Cited
2002
Highly Cited
2002
Improvement of high fat-diet-induced insulin resistance in dipeptidyl peptidase IV-deficient Fischer rats.
Highly Cited
2000
Highly Cited
2000
GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro
Highly Cited
1999
Highly Cited
1999
Biological activity of GLP-1-analogues with N-terminal modifications
Highly Cited
1998
Highly Cited
1998
A synthetic glucagon-like peptide-1 analog with improved plasma stability.
Glucagon-like peptide-1 (GLP-1) is the most potent endogenous insulin-stimulating hormone. In the present study the plasma… 
Highly Cited
1997
Highly Cited
1997
Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.
The GLP-1 structurally related peptides exendin-4 and exendin(9-39)amide were found to act, in rat liver and skeletal muscle, as… 
Review
1996
Review
1996
Human Studies with Glucagon‐like‐peptide‐1: Potential of the Gut Hormone for Clinical Use
So far, a wealth of data originating from in vitro or animal experiments has been collected supporting the concept that the gut… 
1993
1993
Postprandial release of glucagon-like peptide-1, pancreatic glucagon, and insulin after esophageal resection.
Postprandial concentrations of glucose and the immunoreactivity of insulin, glucagon-like peptide-1 (GLP-1), and pancreatic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)